Related references
Note: Only part of the references are listed.Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II
Qian Han et al.
BIOSCIENCE REPORTS (2008)
Mechanisms of neurodegeneration in Huntington's disease
Joana M. Gil et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Crosstalk between astrocytes and motor neurons: What is the message?
L. Van Den Bosch et al.
EXPERIMENTAL NEUROLOGY (2008)
Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases
Ray Truant et al.
FEBS JOURNAL (2008)
A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats
Denise Manahan-Vaughan et al.
HIPPOCAMPUS (2008)
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
Jessica B. Katz et al.
IMMUNOLOGICAL REVIEWS (2008)
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors
Sanjeev Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A
Gavin Carr et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase
Sanjeev Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Xanthurenic acid distribution, transport, accumulation and release in the rat brain
Serge Gobaille et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Immune escape as a fundamental trait of cancer: focus on IDO
G. C. Prendergast
ONCOGENE (2008)
Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: The therapeutic potentials for schizophrenia
Charles R. Yang et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat
Alessandro Gozzi et al.
PSYCHOPHARMACOLOGY (2008)
Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment
Flaviano Giorgini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells
Stefan Lob et al.
BLOOD (2008)
Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia
Franca Rossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The involvement of astrocytes and kynurenine pathway in Alzheimer's disease
Ka Ka Ting et al.
NEUROTOXICITY RESEARCH (2007)
IDO expression in the brain: a double-edged sword
Erik Kwidzinski et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Characterization of the kynurenine pathway in human neurons
Gilles J. Guillemin et al.
JOURNAL OF NEUROSCIENCE (2007)
The kynurenic acid hypothesis of schizophrenia
Sophie Erhardt et al.
PHYSIOLOGY & BEHAVIOR (2007)
Tumor immune escape mediated by indoleamine 2,3-dioxygenase
Maria Zamanakou et al.
IMMUNOLOGY LETTERS (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain
Paolo Guidetti et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis
T. Enomoto et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2007)
Indoleamine 2,3-dioxygenase in immune suppression and cancer
Alexander J. Muller et al.
CURRENT CANCER DRUG TARGETS (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Kynurenic acid leads, dopamine follows: A new case of volume transmission in the brain?
H. -Q. Wu et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
Daniel Kondziella et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease
Zsuzsanna Hartai et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Exiguamine A, an indoleamine-2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosia exigua
Harry C. Brastianos et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35
Jinghong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra
Elizabeth Knyihar-Csillik et al.
ACTA NEUROPATHOLOGICA (2006)
Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice
Paolo Guidetti et al.
NEUROBIOLOGY OF DISEASE (2006)
Modulators of the kynurenine pathway of tryptophan metabolism:: Synthesis and preliminary biological evaluation of (S)-4-(ethylsulfonyl)benzoylaianine, a potent and selective kynurenine aminotransferase II (KAT II) inhibitor
Roberto Pellicciari et al.
CHEMMEDCHEM (2006)
Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder
CL Miller et al.
BRAIN RESEARCH (2006)
Structure-activity study of Brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors
P Gaspari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease
MT Sapko et al.
EXPERIMENTAL NEUROLOGY (2006)
Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys
P Samadi et al.
MOVEMENT DISORDERS (2005)
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
N Stoy et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
A Rassoulpour et al.
JOURNAL OF NEUROCHEMISTRY (2005)
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease
F Giorgini et al.
NATURE GENETICS (2005)
Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral Sclerosis
Gilles J. Guillemin et al.
NEURODEGENERATIVE DISEASES (2005)
The pyridine ring of NAD is formed by a nonenzymatic pericyclic reaction
KL Colabroy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis:: inhibition and degradation of human indoleamine 2,3-dioxygenase
C Hucke et al.
INFECTION AND IMMUNITY (2004)
Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance
A Honig et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
P Guidetti et al.
NEUROBIOLOGY OF DISEASE (2004)
Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment
E Knyihar-Csillik et al.
NEUROSCIENCE (2004)
Decreased serum levels of D-serine in patients with schizophrenia - Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
K Hashimoto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Tolerance, DCs and tryptophan: much ado about IDO
U Grohmann et al.
TRENDS IN IMMUNOLOGY (2003)
Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities
R Schwarcz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures
R Carpenedo et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Endogenous kynurenines as targets for drug discovery and development
TW Stone et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease
GJ Guillemin et al.
REDOX REPORT (2002)
3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote α-crystallin cross-linking by metal ion reduction
LE Goldstein et al.
BIOCHEMISTRY (2000)
Early kynurenergic impairment in Huntington's Disease and in a transgenic animal model
P Guidetti et al.
NEUROSCIENCE LETTERS (2000)
Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway
YH Dang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Share Paper
